Asia Biotech Live
LATEST UPDATES » Vol 24, No 01, January 2020 – Empowering the Patient - Personalization of Diabetes Management       » First of its kind Human Heart-in-a-Jar Model for therapeutic solutions       » China's National Vaccine Tracking System set to be completed in 2020       » China's amended drug administration law kicks in       » Human activity puts Chinese plant biodiversity at risk, study finds       » Contributory effects of each brain cell type in development of Alzheimer's Disease      
INSIDE INDUSTRY For e-subscribers (PDF)
Vol 24, No. 01, January 2020
Providing emotional support for patients with Type 2 Diabetes

Abbott and Diabetes Singapore partner to support Singaporeans with diabetes and their caregivers by providing essential information and skills to better understand and tackle Diabetes Burnout.

Netherlands-based speciality chemicals and food ingredients distributor opens its doors to Asia Pacific

IMCD N.V. (IMCD), a distributor of speciality chemicals and food ingredients, announces the expansion of its global network of Pharmaceutical Technical Centres with the opening of three new locations in India, Southeast Asia and China.

First of its kind Human Heart-in-a-Jar Model for therapeutic solutions

Global stem cell biotechnology company, Novoheart collaborates with AstraZeneca to co-develop the first Human Heart-in-a-Jar Model of heart failure to provide a unique solution for future assessment of novel therapeutics.

More than one million dollars of grants awarded to HIV-related community-led projects in Asia

Gilead Sciences announced in November 2019 the recipients of its 2019 Gilead Asia Pacific Rainbow Grant Programme.

Impact of chronic stress-related conditions on health expenditure

In a report by Cigna and Asia Care Group, the impact of stress-related conditions on Singapore's health system is estimated to amount to a US$23 billion of expenditure.

Addressing needs of Asia's Agri-Food production ecosystem

800 agribusinesses, food brands, investors and innovators gather during the Asia-Pacific Agri-Food Innovation Summit to discuss innovations and investment in the regions agri-food production.

Health Sciences Authority in Singapore approves world-first medical AI Software

See-Mode Technologies, a MedTech start-up based in Singapore and Australia has announced in December 2019 that it has achieved regulatory approval for its debut product.

Using artificial intelligence for greater cost transparency in healthcare expenditure

Singapore-based health start-up, UCARE.AI announced in December 2019 the use of its innovative AI-Powered Pre-Admission Cost of Hospitalisation Estimation (APACHETM) system by private healthcare provider Parkway Pantai.

Official launch of NSG BioLabs first co-working laboratory and office space in Singapore

At 15,000 sq. ft., NSG BioLabs is the largest centre of its kind and will offer companies and entrepreneurs with a flexible and fully-equipped environment that can help biotech firms and investors leverage Singapore's research strength to innovate breakthrough biotech ventures.

Creating cell-based solutions to meet global protein demands

Japanese cell-based technology company, IntegriCulture Inc., leverages on cell culture techniques to create cell-based meat.

news Joining Forces to Elevate Asia's Healthcare Industry
news 4th Global Feed Summit draws Feed Producers, Technology Providers, Raw Materials Suppliers to Bangkok for Key Discussions
news 2nd China Pharma Digital Innovation Summit to be held in Shanghai
news 2nd China Healthcare Digital Innovation Summit to be held in Shanghai

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy